Hammond Janet MJ (CIK 1829899) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-03). Recent activity: Buy AVIR (58,050 shares), Sell AVIR (14,136 shares), Buy AVIR (46,800 shares), Buy AVIR (11,250 shares), Sell AVIR (14,134 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-03 | Atea Pharmaceuticals, Inc. (AVIR) | Chief Development Officer | Buy | 58,050 | $0 |
| 2026-02-03 | Atea Pharmaceuticals, Inc. (AVIR) | Chief Development Officer | Sell | 14,136 | $59,937 |
| 2025-02-04 | Atea Pharmaceuticals, Inc. (AVIR) | Chief Development Officer | Buy | 46,800 | $0 |
| 2025-02-04 | Atea Pharmaceuticals, Inc. (AVIR) | Chief Development Officer | Buy | 11,250 | $0 |
| 2025-02-04 | Atea Pharmaceuticals, Inc. (AVIR) | Chief Development Officer | Sell | 14,134 | $43,250 |
Source: SEC Form 4 filings · as of 2026-02-03